Fengwei Li
, #225 Changhai Road
Shanghai, 200438, China
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: A study based on single-cell and spatial transcriptomic sequencing.
Journal: Hepatology (Baltimore, Md.)
Published: November 14, 2024
YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
Journal: The journal of gene medicine
Published: February 18, 2024
Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma.
Journal: Genomics
Published: December 05, 2022
3,5,3'-Triiodothyronine-Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages.
Journal: Frontiers in oncology
Published: February 17, 2022
The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages.
Journal: Cell & bioscience
Published: March 29, 2021
ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.
Journal: Cancer cell international
Published: September 22, 2020
SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway.
Journal: Molecular therapy. Nucleic acids
Published: July 10, 2020
LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
Journal: Cell death & disease
Published: April 30, 2020
Last Updated: 09/26/2026